Detalles de la búsqueda
1.
BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapy.
Cancer Immunol Immunother
; 72(11): 3461-3474, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37528320
2.
Looking after each other in a crisis-Lessons from Novichok and the parallels with Covid-19.
Nurs Crit Care
; 28(1): 30-35, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34323345
3.
Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitors.
Proc Natl Acad Sci U S A
; 115(21): 5534-5539, 2018 05 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29735668
4.
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer.
BMC Cancer
; 20(1): 445, 2020 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32429929
5.
Identification of NRAS isoform 2 overexpression as a mechanism facilitating BRAF inhibitor resistance in malignant melanoma.
Proc Natl Acad Sci U S A
; 114(36): 9629-9634, 2017 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28827320
6.
Degree of MDM2 Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma.
Oncologist
; 24(7): 989-996, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31019022
7.
An IL-15-based superagonist ALT-803 enhances the NK cell response to cetuximab-treated squamous cell carcinoma of the head and neck.
Cancer Immunol Immunother
; 68(8): 1379-1389, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31338557
8.
MicroRNA-3151 inactivates TP53 in BRAF-mutated human malignancies.
Proc Natl Acad Sci U S A
; 112(49): E6744-51, 2015 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26582795
9.
Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer.
Cancer Immunol Immunother
; 66(11): 1437-1447, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28688082
10.
A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomas.
Cancer Immunol Immunother
; 65(11): 1353-1364, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27581603
11.
Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease.
Cancer Immunol Immunother
; 64(2): 149-59, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25305035
12.
Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With Melanoma.
Front Immunol
; 12: 740890, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34712230
13.
Antibody Conjugation of Fluorescent Nanodiamonds for Targeted Innate Immune Cell Activation.
ACS Appl Nano Mater
; 4(3): 3122-3139, 2021 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34027313
14.
Evidence for interaction of the NLRP3 inflammasome and Bruton's tyrosine kinase in tumor-associated macrophages: implications for myeloid cell production of interleukin-1beta.
Oncoimmunology
; 8(11): 1659704, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31646085
15.
Synergy from gene expression and network mining (SynGeNet) method predicts synergistic drug combinations for diverse melanoma genomic subtypes.
NPJ Syst Biol Appl
; 5: 6, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30820351
16.
Neuroblastoma RAS viral oncogene homolog mRNA is differentially spliced to give five distinct isoforms: implications for melanoma therapy.
Melanoma Res
; 29(5): 491-500, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31116161
17.
Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitro.
J Immunother Cancer
; 7(1): 140, 2019 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31138333
18.
A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell Carcinoma.
Clin Cancer Res
; 25(16): 4955-4965, 2019 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31142501
19.
Analysis of MLN4924 (pevonedistat) as a potential therapeutic agent in malignant melanoma.
Melanoma Res
; 28(5): 390-397, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30020196
20.
Co-stimulation of the fc receptor and interleukin-12 receptor on human natural killer cells leads to increased expression of cd25.
Oncoimmunology
; 7(2): e1381813, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29308301